British obesity levels at crisis point
Britain could see obesity levels soar up to 40 per cent or higher within a single generation unless urgent action is taken, think-tank the International Obesity TaskForce, warned this week.
Britain could see obesity levels soar up to 40 per cent or higher within a single generation unless urgent action is taken, think-tank the International Obesity TaskForce, warned this week.
Japan's Kirin Group has discovered a lactic acid bacteria with potent anti-allergy effects that could be used to fight the rising incidence of allergies, such as hay fever. The research demonstrates the firm's growing interest in the health foods...
Mounting scientific evidence for the therapeutic use of probiotics suggests that these products should be incorporated into conventional medical practices, concluded a recent meeting of experts in probiotics.
Last week's Codex meeting made significant progress in its bid to set global standards on supplements but in Latin America regulations are still variable and closer collaboration will be necessary to improve regional trade, a recent conference heard.
Texas-based Carrington Laboratories has unveiled a new look for product labels and recycled containers to increase brand recognition for the firm's Manapol brand retail merchandise.
A protracted trade dispute over high fructose corn syrup and sugar between Mexico and the US could have cleared an impasse.
Higher raw material costs continue to eat into margins for National Starch, the starch ingredients arm of ICI, as third quarter figures bore out last month. It comes as no surprise this week that the company announced a 'redesign' of operations.
California's Source Naturals has added a stamdardized yerba mate extract to its line, targeting the growing weight loss market and increasing consumer interest in the traditional tea.
The Chinese firm American Oriental Bioengineering is to construct a soybean technology centre, which it claims will produce around 15 per cent of China's total soybean and soy product output.
The main active agent in green tea, EGCG, prevents the first step in HIV infection and could one day be used as a new anti-HIV drug, suggests a new study this week. Japanese researchers report that the extract, already believed to prevent cancer and...